The regulated retrotransposon transcriptome of mammalian cells-Reference-Cited by-同舟云学术

The regulated retrotransposon transcriptome of mammalian cells

Published:2009-04-19 Issue:5 Volume:41 Page:563-571
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Faulkner Geoffrey J,Kimura Yasumasa,Daub Carsten O,Wani Shivangi,Plessy Charles,Irvine Katharine M,Schroder Kate,Cloonan Nicole,Steptoe Anita L,Lassmann Timo,Waki Kazunori,Hornig Nadine,Arakawa Takahiro,Takahashi Hazuki,Kawai Jun,Forrest Alistair R R,Suzuki Harukazu,Hayashizaki Yoshihide,Hume David A,Orlando Valerio,Grimmond Sean M,Carninci Piero

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.368.pdf

Reference50 articles.

1. Levy, S. et al. The diploid genome sequence of an individual human. PLoS Biol. 5, e254 (2007).

2. Margulies, E.H. et al. Comparative sequencing provides insights about the structure and conservation of marsupial and monotreme genomes. Proc. Natl. Acad. Sci. USA 102, 3354–3359 (2005).

3. Babushok, D.V., Ostertag, E.M. & Kazazian, H.H. Jr. Current topics in genome evolution: molecular mechanisms of new gene formation. Cell. Mol. Life Sci. 64, 542–554 (2007).

4. Hasler, J., Samuelsson, T. & Strub, K. Useful 'junk': Alu RNAs in the human transcriptome. Cell. Mol. Life Sci. 64, 1793–1800 (2007).

5. Jurka, J. Evolutionary impact of human Alu repetitive elements. Curr. Opin. Genet. Dev. 14, 603–608 (2004).

Cited by 690 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRescue: uncertainty-aware quantification of transposable elements expression at single cell level;Nucleic Acids Research;2024-09-13

2. The fitness cost of spurious phosphorylation;The EMBO Journal;2024-09-10

3. Targeting transposable elements in cancer: developments and opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. piRNA associates with immune diseases;Cell Communication and Signaling;2024-06-28

5. Potential to use of viral reverse transcriptase inhibitors in oncology;Advances in Molecular Oncology;2024-06-27